De Burlo Group’s ICU Medical ICUI Stock Holding History

De Burlo Group’s Portfolio ICUI Stock Details ICUI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-24,800	Closed	-$7.28M	–	115
2018 Q2	$7.28M	Buy	+24,800	New	+$6.78M	1.54%	22

Other funds holding ICUI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

De Burlo Group's ICUI Position: Q3 2018 in Review

De Burlo Group sold out of ICU Medical (ICUI) in Q3 2018, closing a stake of 24,800 shares — an estimated $7.28M sold.

De Burlo Group first reported a position in ICUI in Q2 2018 and held it in 1 quarter. The position peaked at $7.28M in Q2 2018. 352 funds tracked by Wall St. Rank hold ICUI as of Q3 2018.

De Burlo Group reported no remaining ICU Medical position as of Q3 2018 after selling out during the quarter.
De Burlo Group sold 24,800 ICU Medical shares in Q3 2018, an estimated $7.28M.
De Burlo Group first reported a position in ICU Medical in Q2 2018 and held it in 1 quarter.
De Burlo Group's ICU Medical position peaked at $7.28M in Q2 2018.
352 funds tracked by Wall St. Rank held ICU Medical as of Q3 2018.

Based on De Burlo Group's 13F filing for Q3 2018, filed 8 Nov 2018.